Strategy for producing new foot-and-mouth disease vaccines that display complex epitopes
- 1 January 1996
- journal article
- review article
- Published by Elsevier in Journal of Biotechnology
- Vol. 44 (1-3) , 83-89
- https://doi.org/10.1016/0168-1656(95)00090-9
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Amino acid changes outside the G-H loop of capsid protein VP1 of type O foot-and-mouth disease virus confer resistance to neutralization by antipeptide G-H serumVaccine, 1993
- Identification of a fifth neutralizable site on type O foot-and-mouth disease virus following characterization of single and quintuple monoclonal antibody escape mutantsJournal of General Virology, 1993
- Bovine herpesvirus-1 (infectious bovine rhinotracheitis virus)-based viral vector which expresses foot-and-mouth disease epitopesVaccine, 1991
- The effect of peptides containing the arginine-glycine-aspartic acid sequence on the adsorption of foot-and-mouth disease virus to tissue culture cellsVirus Genes, 1990
- The Cell Attachment Site on Foot-and-Mouth Disease Virus Includes the Amino Acid Sequence RGD (Arginine-Glycine-Aspartic Acid)Journal of General Virology, 1989
- The three-dimensional structure of foot-and-mouth disease virus at 2.9 Å resolutionNature, 1989
- Improved immunogenicity of a peptide epitope after fusion to hepatitis B core proteinNature, 1987
- Protection of Cattle Against Foot-and-Mouth Disease by a Synthetic PeptideScience, 1986
- Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequenceNature, 1982
- Cloned Viral Protein Vaccine for Foot-and-Mouth Disease: Responses in Cattle and SwineScience, 1981